Thibault Gauduchon | Healthcare Data Analysis | Best Researcher Award

Best Researcher Award

Thibault Gauduchon
Centre Léon Bérard, France

Thibault Gauduchon
Affiliation Centre Léon Bérard
Country France
Scopus ID 57979453300
Documents 8
Citations 63
h-index 3
Subject Area Healthcare Data Analysis
Event Research Data Analysis Awards

Thibault Gauduchon is a researcher at Centre Léon Bérard, France, whose scholarly work contributes to healthcare data analysis through clinical data interpretation, oncology research, and evidence-based analytical methodologies. His publication record reflects sustained engagement with multidisciplinary medical research and measurable scientific impact.[1]

Abstract

Thibault Gauduchon’s academic activities emphasize healthcare data analysis within oncology and clinical research. His publications demonstrate the application of analytical methods that support evidence-driven healthcare decisions and improved patient-centered research outcomes.[2]

Keywords

Healthcare Data Analysis, Oncology Research, Clinical Analytics, Medical Informatics, Data Interpretation, Clinical Outcomes, Evidence-Based Medicine, Biomedical Research.

Introduction

His research combines healthcare datasets with clinical expertise to support reliable scientific conclusions. The published studies contribute to understanding disease management and strengthen analytical practices in medical research environments.[3]

Research Profile

Affiliated with Centre Léon Bérard, Thibault Gauduchon has authored eight indexed publications that have accumulated sixty-three citations with a Scopus h-index of three. These metrics indicate a developing research profile in healthcare data analysis.[1]

Research Contributions

His scholarly contributions include clinical data evaluation, oncology-focused investigations, and multidisciplinary collaborations. These studies support improved analytical interpretation and provide evidence useful for advancing healthcare research.[4]

Publications

The publication portfolio spans peer-reviewed medical journals covering oncology and healthcare analytics. The research reflects methodological consistency and demonstrates the practical value of data-driven approaches in clinical investigations.

Research Impact

Citation performance and collaborative publications indicate that his research has contributed to ongoing scientific discussions within healthcare analytics. The measurable academic influence supports continued visibility in international biomedical literature.[1]

Award Suitability

The combination of peer-reviewed publications, citation record, and healthcare data analysis expertise demonstrates qualifications consistent with recognition through the Research Data Analysis Awards. His research contributes to scientific knowledge while supporting practical healthcare improvements.[6]

Conclusion

Thibault Gauduchon’s research profile reflects continuous engagement in healthcare data analysis and clinical investigation. His scholarly achievements and measurable research metrics illustrate an active contribution to evidence-based medical science and academic collaboration.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Thibault Gauduchon, Author ID 57979453300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57979453300
  2. International Committee of Medical Journal Editors. (n.d.). Recommendations for biomedical publications.
  3. World Health Organization. (2023). Global health research and evidence.
  4. Gauduchon, T., Digue, L., Ferlay, C., … Peŕol, D., & Fayette, J. (2026). Efficacy of buparlisib according to PIK3CA mutation status in recurrent or metastatic head and neck squamous cell carcinoma: A multicenter phase II trial. Oral Oncology.
    https://pubmed.ncbi.nlm.nih.gov/42127863/
  5. Research Data Analysis Awards. (2026). International Research Data Analysis Awards.
    https://researchdataanalysis.com/

Liu Yang | Bioinformatics | Best Researcher Award

Prof Dr. Liu Yang | Bioinformatics | Best Researcher Award

Prof Dr. Liu Yang at Department of General Surgery, Jiangsu Cancer Hospital, China

👨‍🎓 Profile

👨‍⚕️ Current Position

Prof. Dr. Yang Liu is a Chief Physician and Associate Professor, serving as the Deputy Head of General Surgery at Jiangsu Cancer Hospital and the Head of Colorectal Surgery at Nanjing Medical University.

📜 Summary

Yang Liu is a prominent figure in colorectal surgery, also acting as a Master’s Supervisor and visiting overseas researcher at Thomas Jefferson University’s BluConner Hospital. His work has earned him multiple accolades in cancer research.

🎓 Education

Yang has completed his medical degree and advanced training in colorectal surgery, although specific institutions are not detailed here.

🏥 Professional Experience

With a focus on complex minimally invasive surgeries, he performs over 150 advanced procedures annually and actively participates in various national and provincial medical associations.

🔬 Research Interests

His research primarily explores ncRNA genomics in relation to colorectal cancer progression and metastasis, alongside developing innovative surgical techniques.

💡 Patents

Yang holds several patents, including:

  • 2024: Combination of Scutellarein for colorectal cancer treatment.
  • 2023: Multi-angle puncture holder.
  • 2020: Circ-0000423 for colorectal cancer drug development.
  • 2019: Surgical retractor for lower abdominal tumors.

🏆 Awards

He has received notable awards such as:

  • 2021: 2nd Prize for New Medical Technology in Jiangsu for epigenetic fusion in colorectal cancer.
  • 2019: 2nd Prize for his study on LINC00152 in colorectal cancer.
📖  Top Noted Publications

LUCAT1 inhibits ferroptosis in bladder cancer by regulating the mRNA stability of STAT3

  • Authors: Cao, Y., Zou, Z., Wu, X., Hu, J., Yang, L.
    Journal: Gene
    Year: 2024

Magnetic resonance imaging-based lymph node radiomics for predicting the metastasis of evaluable lymph nodes in rectal cancer

  • Authors: Ye, Y.-X., Yang, L., Kang, Z., Du, M., Li, Z.-X.
    Journal: World Journal of Gastrointestinal Oncology
    Year: 2024

Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies

  • Authors: Wang, N., Cao, Y., Si, C., Bao, J., Yang, L.
    Journal: Cancers
    Year: 2022

FBXW7 and Its Downstream NOTCH Pathway Could be Potential Indicators of Organ-Free Metastasis in Colorectal Cancer

  • Authors: Li, D., Jiang, S., Zhou, X., Sun, Y., Yang, L.
    Journal: Frontiers in Oncology
    Year: 2022

Anal preservation on the psychology and quality of life of low rectal cancer

  • Authors: Mei, F., Yang, X., Na, L., Yang, L.
    Journal: Journal of Surgical Oncology
    Year: 2022